ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS
Abstract
In this article authors analyze the influence of a label on drug
package on the risk of medication errors and propose methods of their prevention.
Analysis of the corresponding data published by regulators EMA and FDA has
provided an opportunity to find examples of phonetic and graphic similarities
with drugs identification
About the Authors
R. N. Alyautdin
Scientific Centre for Expert Evaluation of Medicinal Products Russian Federation
Russian Federation
Russian Federation
A. P. Pereverzev
Scientific Centre for Expert Evaluation of Medicinal Products Russian Federation
Russian Federation
Russian Federation
B. K. Romanov
Scientific Centre for Expert Evaluation of Medicinal Products Russian Federation
Russian Federation
Russian Federation
N. D. Bunyatyan
Scientific Centre for Expert Evaluation of Medicinal Products Russian Federation
Russian Federation
Russian Federation
References
1. Grissinger M. Avoiding confusion with alphanumeric characters. P&T. 2012; 37: 665, 667.
2. Hoffman JM, Proulx SM. Medication errors caused by confusion of drug n ames. Drug Saf. 2002; 26:445-452.
3. Hampton T. Similar drug n ames: a risky prescri ption. JAMA. 2004; 291: 155-60.
4. HAI Europe/Intern ation al Society of Drug Bulletins/Medicins in Europe Forum. The European Medicines Agency Road Map to 2015: Independence should be the priority; 2010. Available at http://www.isdbweb.org/documents
5. Institute for Safe Medication Practices (ISMP). Available at: http://www.ismp.org/
6. Р.Н. Аляутдин, Б.К. Романов, А.П. Переверзев, Н.Д. Бунятян. Электронная система выписывания рецептов и безопасность лекарственной терапии. Ведомости научного центра экспертизы средств медицинского применения 2014; №2: 30-33.
7. Руководств по разработке дизайна упаковки лекарственных средств, подготовленное Национальным агентством по обеспечению безопасности больных (NHS) и Исследовательским центром Хэлен Хамлин (the Helen Hamlyn research centre). Available
8. at: file:///C:/Users/Pereverzev/Downloads/2858_NPSA_Info_design_second_edition.pdf
9. Рациональный выбор названий лекарственных средств. Методические рекомендации.
10. М.: Федеральная служба по надзору в сфере здравоохранения и социального развития; 2005.
11. Федеральный закон от 12.04.2010 N 61-ФЗ (ред. от 12.03.2014) «Об обращении лекарственных средств».
Review
For citations:
Alyautdin R.N., Pereverzev A.P., Romanov B.K., Bunyatyan N.D. ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS. Safety and Risk of Pharmacotherapy. 2014;(3):15-19. (In Russ.)
Views:
547
Email this article 